Frontiers in medicine · 2026
High-flow nasal cannula oxygenation reduces desaturation risk during diagnostic flexible bronchoscopy under deep sedation: a randomized controlled trial.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Ming, Wang Longfei, Zhou Xuefei, Ming Wanquan, Sheng Cheng, Xu Rong, Wu Youhua, Chen Yongbin, Zhang Yonghua, Cao Yunfei
Аннотация
BACKGROUND: Deep sedation for flexible bronchoscopy (FB) improves procedural conditions but exacerbates desaturation risks. High-flow nasal cannula (HFNC) may mitigate this situation, yet efficacy under deep sedation remains unproven.
METHODS: In this randomized trial (ChiCTR2400083597), 340 ASA I-II patients undergoing FB under deep sedation (MOAA/S ≤ 1) received conventional nasal cannula (5 L/min; NC) or HFNC (25/45/65 L/min). The primary outcomes were the incidence of intraoperative desaturation (SpO₂ < 90% > 10s) and intraoperative nadir SpO₂ value. The intraoperative VAS scores for cough that reflect the stimulation inhibition as a result of deep sedation were used as secondary outcome. Other evaluated outcomes included the EtCO₂ values before induction and after awakening, incidence of intraoperative hypertension/hypotension, postoperative adverse events, as well as the willingness to undergo re-examination.
RESULTS: All procedures were completed in approximately 5 min, without requiring the application of laryngeal mask airway or endotracheal intubation. HFNC groups showed significantly lower desaturation incidence (HF25:16.87%, HF45:12.05%, HF65:5.00%) versus NC (57.14%, p < 0.000), with weak flow-dependence. All HFNC cohorts maintained higher nadir SpO₂ (p < 0.000) and reduced CO₂ retention versus NC (p < 0.05). Cough scores were uniformly low (median VAS:1-1.5), with >97% willingness for repeat FB.
CONCLUSION: The application of HFNC can markedly lower the risks of desaturation during FB under deep sedation in a weak flow-dependent manner, while partially mitigating carbon dioxide accumulation, enabling safer deep sedation without intubation.
METHODS: In this randomized trial (ChiCTR2400083597), 340 ASA I-II patients undergoing FB under deep sedation (MOAA/S ≤ 1) received conventional nasal cannula (5 L/min; NC) or HFNC (25/45/65 L/min). The primary outcomes were the incidence of intraoperative desaturation (SpO₂ < 90% > 10s) and intraoperative nadir SpO₂ value. The intraoperative VAS scores for cough that reflect the stimulation inhibition as a result of deep sedation were used as secondary outcome. Other evaluated outcomes included the EtCO₂ values before induction and after awakening, incidence of intraoperative hypertension/hypotension, postoperative adverse events, as well as the willingness to undergo re-examination.
RESULTS: All procedures were completed in approximately 5 min, without requiring the application of laryngeal mask airway or endotracheal intubation. HFNC groups showed significantly lower desaturation incidence (HF25:16.87%, HF45:12.05%, HF65:5.00%) versus NC (57.14%, p < 0.000), with weak flow-dependence. All HFNC cohorts maintained higher nadir SpO₂ (p < 0.000) and reduced CO₂ retention versus NC (p < 0.05). Cough scores were uniformly low (median VAS:1-1.5), with >97% willingness for repeat FB.
CONCLUSION: The application of HFNC can markedly lower the risks of desaturation during FB under deep sedation in a weak flow-dependent manner, while partially mitigating carbon dioxide accumulation, enabling safer deep sedation without intubation.